Prosecution Insights
Last updated: April 19, 2026

Examiner: GOTFREDSON, GAREN

Tech Center 1600 • Art Units: 1619

This examiner grants 40% of resolved cases

Performance Statistics

40.1%
Allow Rate
-19.9% vs TC avg
593
Total Applications
+29.5%
Interview Lift
1466
Avg Prosecution Days
Based on 536 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
9.2%
§102 Novelty
44.7%
§103 Obviousness
22.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18348787 DENSIFIED CO-PRECIPITATED MATERIALS ISOLATED BY THIN FILM EVAPORATION Non-Final OA Merck Sharp & Dohme LLC
16976023 Tetraselmis Extract Final Rejection SYMRISE AG
18261523 PHARMACEUTICAL COMPOSITION Non-Final OA Novartis AG
18558827 SOTORASIB FORMULATION Non-Final OA AMGEN INC.
19307513 Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases Final Rejection Vektor Pharma TF GmbH
17576404 Preserved Silk Protein Fragment Compositions and Articles Manufactured Therefrom Non-Final OA EVOLVED BY NATURE, INC.
17642829 FLYING PEST CONTROL COMPOSITION AND FLYING PEST CONTROL SPRAY Final Rejection Kao Corporation
16204591 THICK CLEANSING COMPOSITIONS Final Rejection L'OREAL
18516195 PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS Non-Final OA YALE UNIVERSITY
17768166 TARGETED BIFUNCTIONAL DEGRADERS Non-Final OA YALE UNIVERSITY
18176294 TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR Final Rejection Incyte Corporation
17309195 Deodorant Compositions Non-Final OA Colgate-Palmolive Company
18499252 HIGH TEMPERATURE RESISTANT PROBIOTICS FOR FOOD OR BEVERAGE AND METHOD OF MAKING THE SAME Non-Final OA Nano and Advanced Materials Institute Limited
18681221 SCALP MICROBIOME COMPLEX AND USE THEREOF FOR IMPROVING HAIR OR SCALP CONDITION Non-Final OA COSMAX, INC.
18571083 CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS Non-Final OA RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
18757769 Anti-Obesity Agent, Anti-Dementia Agent, Deodorant, Anti-Aging Agent, Anti-Glycation Agent, Anti-Type I Allergy Agent, Hypotensive Agent, Flavor Improving Agent, Muscle Enhancing Agent, and Bone Metabolism Improving Agent Non-Final OA Mitsui DM Sugar Co., Ltd.
18230227 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION Final Rejection KEMIN INDUSTRIES, INC.
18211381 FOLD RESISTANT DEHYDRATED CROSS-LINKED BIOLOGICAL MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Non-Final OA VENUS MEDTECH (HANGZHOU) INC.
18692081 POWDER COSMETIC Non-Final OA SHISEIDO COMPANY, LTD.
17261354 COLOR MIXING SYSTEM FOR COSMETIC COMPOSITION Final Rejection Amorepacific Corporation
17995542 MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE Final Rejection Research Triangle Institute
17597703 MULTILAYER SHEET Non-Final OA Eastman Chemical Company
18291837 TRANSMUCOSAL PATCH COMPRISING A CANNABINOID AND/OR AN OPIOID Non-Final OA Cannamedical Pharma GmbH
17611338 METHODS FOR ENCAPSULATION Non-Final OA Chr. Hansen A/S
17978236 SPHEROIDS FOR SUPPRESSING IMMUNE REJECTION AND USES THEREOF Final Rejection RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY
18563331 COATING FOR MEDICAL DEVICES Non-Final OA SMART REACTORS SERVICE LIMITED
17802054 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND Final Rejection HK INNO.N CORPORATION
17863099 NANOBUBBLE-CONTAINING COSMETIC Final Rejection H4 Co., Ltd.
18268118 USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY Non-Final OA CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA
17781158 Biomaterials for the prevention and the treatment of tissue disorders Final Rejection NOVADIP BIOSCIENCES

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month